Business
Femasys Inc. Announces Existing Board Member Charles Larsen as Chairperson of the Board
Mr. Larsen brings over 40 years of medical device industry experience and skills strongly aligned with the Company’s strategy to strengthen corporate
About this update from Femasys Inc.
[{"type":"text","content":"Mr. Larsen brings over 40 years of medical device industry experience and skills strongly aligned with the Company’s strategy to strengthen corporate governance\nATLANTA, July 06, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that Charles Larsen, a current member of Femasys’ Board of Directors, has been appointed to the role of non-executive Chair, replacing founder, president and chief executive officer, Kathy Lee-Sepsick. Mr. Larsen has served as a member of Femasys’ board of directors since October 2015. Ms. Kathy Lee-Sepsick founder, president and chief executive officer of Femasys, commented, “Charlie’s extensive experience in the medical device industry, executive leadership and experience in strategic transformations, along with his public board experience will provide important insight as we plan to make our novel biomedical solutions available to women worldwide, in support of our mission to change women’s health.” Mr. Larsen, chairperson of Femasys’ board of directors added, “I have spent the entirety of the past 40 years of my career developing medical technologies to address areas of unmet need and improve patient outcomes and I am excited for this opportunity to serve as Chair of the Board. I look forward to working with Kathy Lee-Sepsick, the board and the broader team to continue the development of its lead product candidates, FemaSeed and FemBloc, and preparations for the commercial launch of FemCerv.” Mr. Larsen co-founded Novoste Corporation in 1992 and The Innovation Factory in 1999, and, through his role at The Innovation Factory, he co-founded additional companies including medical device companies such as Acufocus, Inc., AqueSys Inc., Halscion, Inc., Neuronetics, Inc. and Sebacia, Inc. He holds over 30 issued U.S. and international patents on medical devices. Before joining Novoste, Mr. Larsen held positions with Novoste Puerto Rico, Cordis Corporation, Key Pharmaceuticals and Parke-Davis/Warner Lambert in executive, senior engineering, and project management roles. Mr. Larsen also served on the Board of Directors of Acufocus, CardioFocus, Inogen Inc, Intuity Medical Inc., Novoste Inc. and Torax Medica...